Picture of Tego Science logo

191420 Tego Science Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Annual cashflow statement for Tego Science, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line8321,82847.5202-2,343
Depreciation
Amortisation
Non-Cash Items-469-272-10.21,8561,589
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-912-867-169-1,599-588
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities41.41,3184571,040-795
Capital Expenditures-134-337-223-436-1,890
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items210-961-742-2,5553,886
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities76.4-1,298-966-2,9901,996
Financing Cash Flow Items19.10-6.885.1-41.9
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities254-38.51,506148157
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash372-18.4997-1,8021,307